- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Pulling Out the Stops on the Mouse Genome
5 October 1999 7:00 pm
Even as the genome sequencing heavyweights scramble to finish a rough draft of the human genome, they have taken on equally monumental task: churning out a rough draft of the mouse genome by 2003. Today, the National Human Genome Research Institute (NHGRI) announced that it will award $21 million over the next 7 months to jump-start the mouse effort at 10 labs across the United States. "I'm so tickled to be able to start the mouse [sequencing] now," says NHGRI director Francis Collins.
Both human and mouse geneticists share that sentiment. The mouse genome is sometimes described as the human genome chopped into 150 pieces and put back in a different order along the mouse's 21 chromosomes. Because the mouse is so well studied, its sequence will speed the understanding of how our own genes work, says mouse geneticist Barbara Knowles, director of research at the Jackson Laboratory in Bar Harbor, Maine.
The three centers that pulled down the biggest grants are those with the lion's share of the U.S. contribution to human genome sequence: Baylor College of Medicine in Houston, the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, and Washington University School of Medicine in St. Louis. They will have help from a cadre of teams including some that are relatively new to large-scale sequencing, and all will scramble to add more sequencing machines to keep the sequencing of the two genomes on track.
Unlike in the Human Genome Project, teams will be able to request regions of the mouse genome to sequence first. If the plan succeeds in moving along top priority mouse projects, says awardee Raju Kucherlapati, a geneticist at Albert Einstein College of Medicine in New York, "that will be a great strategy."